According to ORIC Pharmaceuticals
's latest financial reports the company has $0.26 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | $0.20 B | -12.96% |
2021-12-31 | $0.23 B | -19.29% |
2020-12-31 | $0.29 B | 229.3% |
2019-12-31 | $89.15 M | 109.12% |
2018-12-31 | $42.63 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
![]() ORIC Pharmaceuticals
ORIC | $0.26 B | 0.00% | ๐บ๐ธ USA |